0 624

Cited 27 times in

Effect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells

DC Field Value Language
dc.contributor.author김호근-
dc.contributor.author박전한-
dc.contributor.author김세종-
dc.date.accessioned2016-02-19T10:59:10Z-
dc.date.available2016-02-19T10:59:10Z-
dc.date.issued2001-
dc.identifier.issn0340-7004-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/142136-
dc.description.abstractMany tumors, including hepatocellular carcinomas (HCCs), resist Fas-mediated cell death, which is one of the effector mechanisms in the host's anti-tumor response; however, this resistance can be abolished by interferon-γ (IFN-γ). IFN-γ may sensitize Fas-mediated cell death in several ways, but the exact mechanism in HCCs is uncertain. In this study, we thoroughly investigated the effect of IFN-γ on the susceptibility of one human normal liver cell line and 12 HCC cell lines to Fas-mediated cell death. We also investigated the effect of IFN-γ on the expression of various apoptosis-related genes such as the Fas/TNF-related genes, the bcl-2 family, and the caspase family of genes. Although most cell lines showed considerable constitutive expression of Fas, all tested cell lines resisted Fas-mediated cell death without IFN-γ. When cells were pretreated with IFN-γ, only three cell lines were made significantly susceptible to Fas-mediated cell death (SNU-354, SNU-387 and SNU-423); the other 10 cell lines were not affected. IFN-γ increased the mRNA expression of Fas, TRAIL and caspase-1, and surface Fas was also increased. The strongly sensitized cell lines (SNU-354, SNU-387 and SNU-423) showed a particularly potent increment in surface Fas after IFN-γ treatment (increase in surface Fas >1.7-fold). This result enabled us to conclude that a potent increment of surface Fas expression is a major sensitizing mechanism of IFN-γ. We conclude that IFN-γ cannot play a sensitizing role in most HCC cell lines and that IFN-γ makes HCC cells susceptible to Fas-mediated cell death through a marked up-regulation of surface Fas in some HCC cells.-
dc.description.statementOfResponsibilityopen-
dc.format.extent23~30-
dc.relation.isPartOfCANCER IMMUNOLOGY IMMUNOTHERAPY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHApoptosis/drug effects*-
dc.subject.MESHCarcinoma, Hepatocellular/pathology*-
dc.subject.MESHCaspase 1/genetics-
dc.subject.MESHGenes, bcl-2-
dc.subject.MESHHumans-
dc.subject.MESHInterferon-gamma/pharmacology*-
dc.subject.MESHLiver Neoplasms/pathology*-
dc.subject.MESHRNA, Messenger/analysis-
dc.subject.MESHTumor Cells, Cultured-
dc.subject.MESHfas Receptor/genetics-
dc.subject.MESHfas Receptor/physiology*-
dc.titleEffect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Microbiology (미생물학)-
dc.contributor.googleauthorEui-Cheol Shin-
dc.contributor.googleauthorWoo-Chul Shin-
dc.contributor.googleauthorYoujeong Choi-
dc.contributor.googleauthorHoguen Kim-
dc.contributor.googleauthorJeon Han Park-
dc.contributor.googleauthorSe Jong Kim-
dc.identifier.doi10.1007/s002620000166-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01183-
dc.contributor.localIdA01641-
dc.contributor.localIdA00603-
dc.relation.journalcodeJ00445-
dc.identifier.eissn1432-0851-
dc.identifier.pmid11315506-
dc.identifier.urlhttp://link.springer.com/article/10.1007/s002620000166-
dc.subject.keywordIFN-γ-
dc.subject.keywordFas-
dc.subject.keywordCell death-
dc.subject.keywordHepatoma-
dc.contributor.alternativeNameKim, Ho Keun-
dc.contributor.alternativeNamePark, Jeon Han-
dc.contributor.alternativeNameKim, Se Jong-
dc.contributor.affiliatedAuthorKim, Ho Keun-
dc.contributor.affiliatedAuthorPark, Jeon Han-
dc.contributor.affiliatedAuthorKim, Se Jong-
dc.rights.accessRightsnot free-
dc.citation.volume50-
dc.citation.number1-
dc.citation.startPage23-
dc.citation.endPage30-
dc.identifier.bibliographicCitationCANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.50(1) : 23-30, 2001-
dc.identifier.rimsid31632-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.